| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 4966* | 2014 |
| Comprehensive genomic characterization of head and neck squamous cell carcinomas Cancer Genome Atlas Network Nature 517 (7536), 576, 2015 | 3505 | 2015 |
| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 926 | 2017 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 725 | 2017 |
| A practical guide to methods controlling false discoveries in computational biology K Korthauer*, PK Kimes*, C Duvallet, A Reyes, A Subramanian, M Teng, ... Genome Biology 20, 118, 2019 | 350 | 2019 |
| The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 345 | 2018 |
| Statistical significance for hierarchical clustering PK Kimes, Y Liu, D Neil Hayes, JS Marron Biometrics 73 (3), 811-821, 2017 | 225 | 2017 |
| Abnormal small intestinal epithelial microvilli in patients with Crohn's disease KL VanDussen, A Stojmirović, K Li, TC Liu, PK Kimes, BD Muegge, ... Gastroenterology 155 (3), 815-828, 2018 | 93 | 2018 |
| Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial L Kist de Ruijter, PP van de Donk, JS Hooiveld-Noeken, D Giesen, ... Nature Medicine 28 (12), 2601-2610, 2022 | 74 | 2022 |
| SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples PK Kimes*, CR Cabanski*, MD Wilkerson, N Zhao, AR Johnson, ... Nucleic Acids Research, gku521, 2014 | 29 | 2014 |
| Risk profiling of patients with previously untreated diffuse large B-cell lymphoma (DLBCL) by measuring circulating tumor DNA (ctDNA): results from the POLARIX study AF Herrera, R McCord, P Kimes, F Jardin, G Lenz, M Trneny, CR Flowers, ... Blood 140 (Supplement 1), 1297-1300, 2022 | 19 | 2022 |
| Glofitamab plus R-CHOP induces high response rates with a manageable safety profile in patients with previously untreated diffuse large B-cell lymphoma (DLBCL): a 12-month … MS Topp, M Tani, M Dickinson, N Ghosh, A Santoro, A Pinto, F Bosch, ... Blood 142, 3085, 2023 | 17 | 2023 |
| Reproducible and replicable comparisons using SummarizedBenchmark PK Kimes*, A Reyes* Bioinformatics (Oxford, England), 2018 | 13 | 2018 |
| Abstract LB037: 89ZED88082A PET imaging to visualize CD8+ T cells in patients with cancer treated with immune checkpoint inhibitor LK de Ruijter, PP van de Donk, JS Hooiveld-Noeken, D Giesen, ... Cancer Research 81 (13_Supplement), LB037-LB037, 2021 | 8 | 2021 |
| Discovery of antibodies and cognate surface targets for ovarian cancer by surface profiling B Schröfelbauer, PK Kimes, P Hauke, CE Reid, K Shao, SJ Hill, R Irizarry, ... Proceedings of the National Academy of Sciences 120 (1), e2206751120, 2023 | 5 | 2023 |
| DNA binding analysis of rare variants in homeodomains reveals homeodomain specificity-determining residues KH Kock*, PK Kimes*, SS Gisselbrecht*, S Inukai, SK Phanor, ... Nature Communications 15 (1), 3110, 2024 | 4* | 2024 |
| P066 Intestinal Epithelial Microvilli Are Abnormal in Crohn’s Disease KL VanDussen, A Stojmirović, L Ta-Chiang, PK Kimes, JG Perrigoue, ... Inflammatory Bowel Diseases 24, S24-S25, 2018 | 1 | 2018 |
| Platform for antibody discovery B Schrofelbauer, P Kimes, W Hahn US Patent App. 18/719,186, 2025 | | 2025 |
| Antibodies and uses thereof B Schrofelbauer, P Kimes, W Hahn US Patent App. 18/719,086, 2025 | | 2025 |
| Deep Learning Predicts Risk of Large B-Cell Lymphoma Progression upon R-CHOP Therapy from Baseline Histology SA Sureshjani, A Yüce, C Doerig, A Mosinska, P Kimes, M Kesavan, ... Blood 144, 108, 2024 | | 2024 |